Today: 8 June 2026
Browse Category

NASDAQ:RGTI 16 November 2025 - 9 December 2025

Quantum Stocks Today After the Bell (December 9, 2025): IonQ, Rigetti, D‑Wave, Arqit and QUBT Pause After a Wild Year

Quantum Stocks Today After the Bell (December 9, 2025): IonQ, Rigetti, D‑Wave, Arqit and QUBT Pause After a Wild Year

Quantum computing stocks ended mixed Tuesday after a volatile year, with IonQ flat at $54.44, D-Wave Quantum down 0.4% at $28.33, Rigetti off 0.2% at $28.22, Quantum Computing Inc. up 1.4% at $13.21, and Arqit Quantum down 0.3% at $29.63. The S&P 500 slipped 0.2% as traders awaited a Federal Reserve decision.
Rigetti Computing (RGTI) Stock News Today: DARPA Setback, Citadel Buying and 2026–2030 Forecasts

Rigetti Computing (RGTI) Stock News Today: DARPA Setback, Citadel Buying and 2026–2030 Forecasts

Rigetti Computing shares traded at $27–28 on December 9, with a market cap just under $10 billion despite trailing 12-month revenue of $7.5 million. The stock is up about 586% over the past year but fell 42% in November after weak Q3 results. Q3 revenue dropped 18% to $1.9 million, with a GAAP net loss of $201 million. Citadel Advisors disclosed a new position of 51,700 shares in the third quarter.
Quantum Stocks Today (Dec. 9, 2025): IonQ, Rigetti, D‑Wave and Arqit Cool After Huge 2025 Rally

Quantum Stocks Today (Dec. 9, 2025): IonQ, Rigetti, D‑Wave and Arqit Cool After Huge 2025 Rally

Quantum computing stocks including IonQ, Rigetti, D-Wave, Arqit, and Quantum Computing Inc. closed mostly flat to slightly lower on Tuesday after sharp multi-year rallies. IonQ ended at $54.35, Rigetti at $27.90, D-Wave at $27.99, and Arqit at $28.94, while Quantum Computing Inc. rose to $13.21. New Zacks research and hedge-fund filings spotlighted growing institutional interest in the sector.
Rigetti Computing (RGTI) Stock: December 8, 2025 News, Analyst Forecasts and Quantum Computing Outlook

Rigetti Computing (RGTI) Stock: December 8, 2025 News, Analyst Forecasts and Quantum Computing Outlook

Rigetti Computing closed at $27.84 on December 8, 2025, down 1%, with a market cap near $9.3 billion. The stock remains up about 730% year-on-year despite a 42% plunge in November after weak Q3 results. JPMorgan increased its stake by 142% in Q2, and institutional investors now hold 35% of the float. The stock’s 52-week range is $3.31 to $58.15.
Rigetti Computing (RGTI) Stock: What to Know Before the Market Opens on December 8, 2025

Rigetti Computing (RGTI) Stock: What to Know Before the Market Opens on December 8, 2025

Rigetti Computing closed Friday at $28.11, down 6.5%, after a sharp reversal from Thursday’s rally. Shares have surged about 2,750% since January 2024 but remain down 57% from October highs. Market cap stands near $9.3 billion, with the stock trading at over 1,000 times sales. New analysis published December 7 highlights debate over valuation and future prospects.
RGTI Stock Today (December 6, 2025): Rigetti Computing’s Volatile Rally, Quantum Roadmap and 2026 Price Forecast

RGTI Stock Today (December 6, 2025): Rigetti Computing’s Volatile Rally, Quantum Roadmap and 2026 Price Forecast

Rigetti Computing shares closed at $28.11 on December 5, down 6.5% for the day on volume of 50.9 million shares. The stock plunged 42% in November after weak Q3 results but remains up 729% over 12 months. Market cap stands at $9.3 billion despite $350 million in losses on $7.5 million in revenue. Recent volatility followed comments from Nobel laureate John Martinis on U.S.–China quantum competition.
Rigetti Computing (RGTI) Stock News and Forecast Today: Quantum Hype, Government Hopes and Bubble Fears – 5 December 2025

Rigetti Computing (RGTI) Stock News and Forecast Today: Quantum Hype, Government Hopes and Bubble Fears – 5 December 2025

Rigetti Computing shares traded near $28 Friday afternoon, down from Thursday’s close of about $30 but still up sharply from earlier in the week. The stock surged over 15% Thursday on heavy volume after a 42% drop in November. Rigetti’s 12-month gain at one point neared 5,400%. Market cap now fluctuates between $9 billion and $11 billion.
Rigetti Computing (RGTI) Stock: From 42% November Plunge to December Rebound – Latest News, Forecasts and Analysis (Dec 5, 2025)

Rigetti Computing (RGTI) Stock: From 42% November Plunge to December Rebound – Latest News, Forecasts and Analysis (Dec 5, 2025)

Rigetti Computing shares traded near $30.06 on December 5, up 17–18% in a week and about 866% over the past year, with a market cap close to $9.9 billion. The stock remains volatile after a 42% plunge in November and a 15% rebound on December 4, despite trailing-12-month revenue of $7.5 million and negative EBITDA near $73 million. CEO Subodh Kulkarni holds no shares after recent insider sales.
Rigetti Computing (RGTI) Stock on December 4, 2025: Q3 Earnings Shock, Quantum Roadmap and 2026–2027 Forecasts

Rigetti Computing (RGTI) Stock on December 4, 2025: Q3 Earnings Shock, Quantum Roadmap and 2026–2027 Forecasts

Rigetti shares traded near $28 on December 4, down about 42% for November but still up over 700% year-on-year. Q3 revenue fell 21% to $1.9 million, with a GAAP net loss of $201 million. The company reported $600 million in cash and is targeting a 1,000+ qubit system by 2027. Analyst targets range widely, with an average of $40.60.
Rigetti Computing (RGTI) Stock on December 2, 2025: Price, Quantum Roadmap, Analyst Targets and Key Risks

Rigetti Computing (RGTI) Stock on December 2, 2025: Price, Quantum Roadmap, Analyst Targets and Key Risks

Rigetti Computing shares traded at $23.98 late on December 2, up 2% after heavy losses in November wiped out much of its 2025 rally. The stock has swung between $2.40 and $58.15 over the past year and now carries a market cap near $8 billion, despite 2024 revenue of just $10.8 million. Trading volume topped 20 million shares. AI models expect continued volatility and label the stock high risk.
Rigetti Computing (RGTI) Stock on December 1, 2025: Options Surge, Institutional Buying and a High‑Risk Quantum Roadmap

Rigetti Computing (RGTI) Stock on December 1, 2025: Options Surge, Institutional Buying and a High‑Risk Quantum Roadmap

Rigetti Computing shares closed at $24.19 on December 1, 2025, up about 55% year-to-date but well below their $58.15 high. The company’s market cap stands near $8.4 billion despite low revenues and steep losses. Options trading surged, with 58,000 contracts and a put/call ratio of 0.41. Short interest is about 15.9% of float.
Rigetti Computing (RGTI) Stock on November 25, 2025: Volatile Pullback as Insider Selling, NQI Funding and New ETF Collide

Rigetti Computing (RGTI) Stock on November 25, 2025: Volatile Pullback as Insider Selling, NQI Funding and New ETF Collide

Rigetti Computing shares fell 4–5% to around $25–26 in heavy trading on November 25, despite new government funding and the launch of an ETF tied to its stock. The drop follows insider sales by top executives and comes as the stock remains up several hundred percent over the past year but down over 40% from October highs. Market cap stands near $8.4 billion on trailing revenue of $7.5 million and a net loss of $351 million.
RGTI Stock Today, November 25, 2025: Rigetti Computing Pulls Back as Insider Selling and New Quantum ETFs Fuel Volatility

RGTI Stock Today, November 25, 2025: Rigetti Computing Pulls Back as Insider Selling and New Quantum ETFs Fuel Volatility

Rigetti Computing shares traded near $25.5 Tuesday afternoon, down about 4% after a month-long 41% slide. The stock remains up several hundred percent year-over-year, despite heavy volatility and trading volume dropping to around 15 million shares. Rigetti’s Q3 2025 revenue fell to about $1.9 million, with a net loss of $201 million for the quarter. The company’s valuation stands at roughly $8.4 billion.
Quantum Computing Stocks Are Booming: Top 5 to Buy Now (October 2025)

Quantum Computing Stocks This Week (Nov 16–21, 2025): IonQ Slide, QUBT Spike, Rigetti and D‑Wave in Focus

IonQ stabilized after steep losses, buoyed by inclusion in Deloitte’s Technology Fast 500. Quantum Computing Inc. posted $384,000 in Q3 revenue but turned a profit and surged on a large capital raise. Rigetti drew mixed analyst calls and insider selling. D‑Wave’s CFO sold $4.6 million in stock despite improved fundamentals.
Quantum Computing Inc (QUBT) Stock Skyrockets on $500M Fundraising and New Tech Debut – Can the Rally Last?

Quantum Computing Stocks Today (November 17, 2025): IonQ’s Skyloom Deal, QUBT Earnings Surge, D‑Wave Insider Selling

IonQ announced it will acquire Skyloom Global, aiming to expand its quantum-networking capabilities. Quantum Computing Inc. shares surged 8.5% after posting a surprise profit and unveiling a new product. Rigetti fell 3.1% despite an analyst upgrade, while D-Wave dropped 3.4% on insider selling. NVIDIA and RIKEN introduced new supercomputers for AI and quantum workloads.
Rigetti’s Quantum Leap: Stock Jumps 5,000% and Then Grinds Back – Bubble or Breakthrough?

Rigetti Computing (RGTI) Stock: Q3 2025 Shock, Insider Selling and a High‑Risk Quantum Bet – Analysis & Forecast (Updated November 16, 2025)

Rigetti Computing shares closed at $25.48 on Nov. 14, down 24% in a week and over 50% below recent highs, but still up more than 1,500% year-on-year. Q3 results showed an adjusted loss of $0.03 per share, beating estimates, but revenue missed at $1.9 million. Insiders sold about 1 million shares in six months, while major institutions increased stakes. Market cap stands near $8.4 billion on $7.5 million in annual revenue.
16 November 2025
1 3 4 5 6 7

Stock Market Today

  • KOSPI Index Plunges Amid Global Market Turmoil
    June 8, 2026, 9:07 AM EDT. South Korea's KOSPI experienced a sharp crash triggered by margin stress in chip stocks and a circuit breaker trading halt. The selloff in global markets was fueled by a strong U.S. jobs report signaling prolonged high interest rates, fears of a yen carry trade unwind amid Bank of Japan tightening, and a crypto selloff following Zcash network vulnerabilities. U.S. futures rebounded slightly as chip stocks recovered, with investors focused on upcoming inflation data and SpaceX's anticipated IPO. Rising Middle East tensions keep oil prices elevated near $94 per barrel. The volatile market reflects growing concerns over liquidity absorption from the SpaceX listing, geopolitical risks, and tightening monetary policies globally.

Latest articles

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
ABAT Shares Jump on DOE’s $115M Lithium Grant Return

ABAT Shares Jump on DOE’s $115M Lithium Grant Return

8 June 2026
American Battery Technology Co shares soared 29.58% to $4.03 premarket after the U.S. Department of Energy fully reinstated a $115 million grant for its Nevada lithium refinery, restoring federal funding for the Tonopah Flats Lithium Project with no change to awarded funds or milestones, though risks remain from permitting, financing, and volatile lithium prices.
NANO Nuclear Stock Bounces, Investors Eye What’s Next

NANO Nuclear Stock Bounces, Investors Eye What’s Next

8 June 2026
NANO Nuclear Energy jumped 7.8% to $25.40 in premarket trading after a 9.9% Friday drop, as traders weighed fresh insider sales filings and recent regulatory progress on its KRONOS microreactor project; the company held $568.7 million in cash as of March 31, but faces sector-wide volatility and execution risks.
Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

8 June 2026
Nurix soared 20.4% to $17.62 premarket after Roche agreed to pay $700 million up front in a bexobrutideg collaboration worth up to $2.3 billion, a major cash boost and external validation for Nurix’s lead blood cancer drug ahead of a planned Phase 3 trial, with Roche’s clinical and commercial backing now in play.
Go toTop